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İntratekal yüksek doz metotreksatın yanlışlıkla uygulanması
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We  read  your  recent  article  about  intrathecal 
methotrexate  overdose  with  great  interest  [1].
Although intrathecal methotrexate overdose rarely 
occurs, it is frequently lethal and may result in neu-
rologic  sequelae.  Thus,  new  case  reports  may 
enhance  our  knowledge  of  this  potentially  lethal 
toxicity.  Intrathecal  methotrexate  overdose  was 
accidentally administered to two children that sub-
sequently developed progressive neurologic symp-
toms  and  signs  shortly  afterwards;  however,  no 
neurologic manifestations were observed in a case 
we recently published, which resulted in delayed 
recognition  of  the  intrathecal  methotrexate  over-
dose  [2].  An  intrathecal  dose  of  50-120  mg  may 
cause no or mild neurologic signs. There seems to 
be variation in neurologic signs that may be related 
to  differences  in  cerebrospinal  fluid  dynamics 
between individuals [3,4]. 
Various EEG patterns reported in patients with 
methotrexate  overdose  may  have  been  due  to 
intrathecal methotrexate overdose or due to sys-
temic high-dose methotrexate given concomitant-
ly [2,5,6]. We observed EEG findings indicative of 
encephalopathy in our patient, including slow acti-
vation increase in the background and paroxysmal 
activation of the temporal region [2]; however, we 
did  not  administer  anticonvulsant  therapy  to  the 
patient because she did not have any neurologic 
symptom.
Current  management  recommendations  for 
intrathecal  methotrexate  overdose  are  based  on 
case reports and small case series. It is important to 
drain  the  cerebrospinal  fluid  as  soon  as  possible 
after overdose is determined. We think cerebrospi-
nal exchange, as described in Kazancı et al.’s cases 
and our case, is more effective [1,2]. Concomitant 
administration of high-dose folinic acid rescue and 
dexamethasone are recommended in all published 
reports [1]. 
The cause of intrathecal methotrexate overdose 
in our case was accidental intrathecal administra-
tion of higher intravenous dose vial in small volume 
[2],  which  resulted  from  the  resemblance  of  the 
labels of two different strength methotrexate prepa-
rations, as reported by Kazancı et al. [1]. As previ-
ously suggested, to prevent this lethal error, sepa-
rate  package-specific  labeling  of  preparations  for 
intrathecal and intravenous use by pharmaceutical 
companies may be helpful [7].
In conclusion, accidental intrathecal methotrexate 
overdose may not cause neurologic symptoms; how-
ever, in cases of delayed recognition of intrathecal 
methotrexate  overdose  the  treatment  protocol  that 
was successfully used in our case is recommended. Conflict of interest statement
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